MET/VEGFR-2 inhibitor GSK1363089

{
  "id": "MLC-T-ONC-005335",
  "term": "MET/VEGFR-2 inhibitor GSK1363089",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. MET/VEGFR-2 inhibitor GSK1363089 blocks enzymes involved in the growth and spread of tumor cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called foretinib and XL880.",
  "synonyms": [
    "foretinib",
    "XL880"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/met-vegfr-2-inhibitor-gsk1363089/"
}